Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-05-01 @ 11:37 PM
Study NCT ID:
NCT04652258
Status:
TERMINATED
Last Update Posted:
2024-11-01
First Post:
2020-11-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
Sponsor:
University of Zurich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NovartisIIT/ 2020-01929
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None